Genelux Insider Trades
NASDAQ: GNLXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 24 · $340.56K
- Shares bought / sold
- 0 / 115.77K
- Net activity
- Net selling $340,565
Genelux insider activity
Over the last 12 months, Genelux insiders reported 33 transactions on SEC Form 4: 0 open-market purchases and 24 sales. Insiders bought $0 and sold $340,565 worth of stock, for net insider selling of $340,565. The largest seller was Zindrick Thomas, with $124,016 in reported sales.
The most recent filing shows Zindrick Thomas (President and CEO) selling 3,089 shares at $2.05 on Nov 3, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put GNLX's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
GNLX insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Nov 3, 2026 | Cappello JosephChief Technical Officer | Sale | 668 | $1.36K | Form 4 |
| Nov 3, 2026 | Yu YongChief Scientific Officer | Sale | 668 | $1.34K | Form 4 |
| Nov 3, 2026 | Zindrick ThomasPresident and CEO | Sale | 3,089 | $6.32K | Form 4 |
| Aug 31, 2026 | Yu YongChief Scientific Officer | Sale | 9,683 | $26.66K | Form 4 |
| Aug 31, 2026 | Zindrick ThomasPresident and CEO | Sale | 34,463 | $91.90K | Form 4 |
| Aug 31, 2026 | Cappello JosephChief Technical Officer | Sale | 10,257 | $28.11K | Form 4 |
| Aug 4, 2026 | Cappello JosephChief Technical Officer | Sale | 653 | $1.92K | Form 4 |
| Aug 4, 2026 | Zindrick ThomasPresident and CEO | Sale | 3,023 | $8.91K | Form 4 |
| Aug 4, 2026 | Yu YongChief Scientific Officer | Sale | 653 | $1.92K | Form 4 |
| Jul 1, 2026 | Smither John WDirector | Sale | 12,000 | $34.90K | Form 4 |
| Jun 16, 2026 | Smither John WDirector | Award | 28,409 | — | Form 4 |
| Jun 16, 2026 | Tyree James LDirector | Award | 28,409 | — | Form 4 |
| Jun 16, 2026 | Cappello JosephChief Technical Officer | Award | 174,841 | — | Form 4 |
| Jun 16, 2026 | Yu YongChief Scientific Officer | Award | 119,318 | — | Form 4 |
| Jun 16, 2026 | Mirabelli MaryDirector | Award | 28,409 | — | Form 4 |
| Jun 16, 2026 | Thomas JohnDirector | Award | 28,409 | — | Form 4 |
| Jun 16, 2026 | Zindrick ThomasPresident and CEO | Award | 730,601 | — | Form 4 |
| Jun 16, 2026 | Groen EricGeneral Counsel | Award | 233,957 | — | Form 4 |
| Jun 16, 2026 | Pulisic MatthewChief Financial Officer | Award | 278,906 | — | Form 4 |
| Jun 3, 2026 | Smalling RalphHead of Regulatory | Sale | 192 | $562.56 | Form 4 |
| Jun 1, 2026 | Thomas JohnDirector | Sale | 10,000 | $29.80K | Form 4 |
| May 11, 2026 | Cappello JosephChief Technical Officer | Sale | 605 | $1.80K | Form 4 |
| May 11, 2026 | Smalling RalphHead of Regulatory | Sale | 270 | $804.49 | Form 4 |
| May 11, 2026 | Zindrick ThomasPresident and CEO | Sale | 2,798 | $8.23K | Form 4 |
| May 11, 2026 | Yu YongChief Scientific Officer | Sale | 605 | $1.80K | Form 4 |
| Mar 25, 2026 | Smalling RalphHead of Regulatory | Sale | 240 | $602.40 | Form 4 |
| Mar 24, 2026 | Zindrick ThomasPresident and CEO | Sale | 3,582 | $8.67K | Form 4 |
| Mar 24, 2026 | Yu YongSVP, Clinical Development | Sale | 906 | $2.19K | Form 4 |
| Mar 24, 2026 | Cappello JosephChief Technical Officer | Sale | 906 | $2.19K | Form 4 |
| Mar 24, 2026 | Smalling RalphHead of Regulatory | Sale | 345 | $834.90 | Form 4 |
| Mar 2, 2026 | Thomas JohnDirector | Sale | 10,000 | $28.96K | Form 4 |
| Dec 5, 2025 | Smalling RalphHead of Regulatory | Sale | 165 | $773.85 | Form 4 |
| Dec 1, 2025 | Thomas JohnDirector | Sale | 10,000 | $50.01K | Form 4 |
| Nov 17, 2025 | Smalling RalphHead of Regulatory | Sale | 343 | $1.84K | Form 4 |
| Nov 17, 2025 | Cappello JosephChief Technical Officer | Sale | 973 | $5.22K | Form 4 |
| Nov 17, 2025 | Zindrick ThomasPresident and CEO | Sale | 4,509 | $24.21K | Form 4 |
| Nov 17, 2025 | Yu YongSVP, Clinical Development | Sale | 973 | $5.22K | Form 4 |
| Sep 3, 2025 | Smalling RalphHead of Regulatory | Sale | 580 | $1.95K | Form 4 |
| Sep 1, 2025 | Smalling RalphHead of Regulatory | Award | 10,000 | — | Form 4 |
| Aug 27, 2025 | Smalling RalphHead of Regulatory | Award | 26,230 | — | Form 4 |
| Aug 27, 2025 | Zindrick ThomasPresident and CEO | Award | 361,200 | — | Form 4 |
| Aug 27, 2025 | Thomas JohnDirector | Award | 22,283 | — | Form 4 |
| Aug 21, 2025 | Smalling RalphHead of Regulatory | Sale | 1,244 | $4.18K | Form 4 |
| Aug 21, 2025 | Cappello JosephChief Technical Officer | Sale | 1,463 | $4.91K | Form 4 |
| Aug 21, 2025 | Cappello JosephChief Technical Officer | Sale | 1,270 | $4.22K | Form 4 |
| Aug 21, 2025 | Zindrick ThomasPresident and CEO | Sale | 12,673 | $42.16K | Form 4 |
| Aug 21, 2025 | Yu YongSVP, Clinical Development | Sale | 3,219 | $10.81K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4